Author:
Bärenholdt Olaf,Kolthoff Niels,Nielsen Stig Pors
Subject
Histology,Physiology,Endocrinology, Diabetes and Metabolism
Reference26 articles.
1. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis — a 2-year randomized placebo controlled trial;Meunier;J. Clin. Endocrinol. Metab.,2002
2. Strontium ranelate reduces the risk of vertebral fracture in women with postmenopausal osteoporosis;Meunier;N. Engl. J. Med.,2004
3. Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis (TROPOS) study;Reginster;J. Clin. Endocrinol. Metab.,2005
4. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate;Bruyere;J. Clin. Endocrinol. Metab.,2007
5. Effects of strontium ranelate on bone mineral density and fracture risk — a meta-analysis;Vestergaard;Calcif. Tissue Int.,2007
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献